"Insights from Industry" is a dynamic series of interviews at the cutting edge of the life sciences industry.
Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible
insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
There are many differences between colloidal silver and ionic silver solutions. Philip Marshall discusses what makes these silver solutions unique.
An interview with Dr Natarajan Ranganathan, key founder and Managing Director of Kibow Biotech Inc. about the use of probiotics for supporting healthy kidney function.
In this interview, Neil Benn talks to News-Medical about their range of 2d barcode scanners that are making sample management digital in the laboratory.
In this interview, Cedric Uytingco discusses the key benefits of being able to visualize gene expression patterns in neurological samples.
In this interview, Peter Awram discusses the benefits of NMR spectroscopy as an analytical technique for the honey industry, in the fight against fraud.
Driving adoption of digital pathology through the Scan Image Search from Huron Digital Pathology. Patrick Myles talks to the Dell Healthcare PowerChat Podcast.
In this interview, Dr. Dave Fancy, CEO of Jackson ImmunoResearch explains how anti-VHH antibodies can be used to produce nanobodies and VHH libraries.
There have been clear statements from regulatory bodies that have increased the pressure on pharmaceutical companies to go electronic with their records and ensure a high level of data integrity in all areas of the pharmaceutical industry.
Until recently, cells were typically counted on a reusable quartz hemocytometer. With the advent of automated cell counters 12-15 years ago, disposable slides became widespread.
The Chromatrap ChIP technology is a bead-free method of performing ChIP. The potential of the technology emerged from our capabilities in manufacturing porous plastic filters for the filtration and separation of biological materials.
Harnessing the interactions between DNA, RNA, and proteins holds much promise for detecting biomarkers, diagnosing disease, and improving cancer-targeting therapeutics. Quantifying these interactions is essential for understanding and controlling their biomolecular mechanisms.
PIPPI scientists from different fields are developing methodologies, tools, and databases to guide the rational formulation of robust protein-based therapeutics. Their overall goal is to develop a database to guide product formulation development.
In this interview, Prof. Elborn and Dr. Dixon discuss the issues involving chronic lung conditions such as cystic fibrosis and bacterial respiratory infections.
An interview with Bob Schuman discussing the development of a flexible NIR spectrometer that is enabling analysis at the production line itself.
News-Medical speaks to Brad Harrison and Artem Egorov about the analysis of common but potentially lethal compounds in food and beverages.
In this interview Dr Kushol Gupta, Research Assistant Professor in the Department of Biochemistry and Biophysics at the Perelman School of Medicine, University of Pennsylvania talks to News-Medical and Life Sciences about the importance of light scattering techniques for investigating structure and mechanism of action in his ongoing research into HIV integrase and the development of HIV therapeutics.
In this interview, CEM Corporation talks to News-Medical Life Sciences about using their product the Liberty Blue for Automated High-Efficiency Solid Phase Peptides Synthesis of Modified and Pharmaceutically Relevant Peptides.
The purpose of antibody protein sequencing is to accurately deduce every single amino acid present in the primary sequence. This is an issue with isoleucine and leucine which have the same molecular weight. Rapid Novor has developed a technique to determine these with 100% accuracy.
In this interview, Marcel Lachenmann describes the importance of characterizing small molecules in the pharma, food and polymer industry and how NMR achieves this.
Labs are demanding purity and flexibility for high throughput nucleic acid purification, while needing to complete difficult downstream analysis, for example with Next Gen Sequencing (“NGS”)